Expands the type of certifications that may be accepted by the state of New York for restricted licenses; requires individuals may only perform toxicology testing in a laboratory authorized by the state of New York.
Impact
The proposed changes in A10564 impact state laws governing clinical laboratories and their operations. By expanding the scope of acceptable certifications, the bill attempts to enhance the capabilities of the workforce in the field of clinical laboratory technology. This could potentially improve public health outcomes by ensuring that qualified personnel are able to perform necessary tests in licensed facilities, thereby maintaining high standards in laboratory practices.
Summary
A10564 aims to amend the education law to expand the types of certifications that may be accepted by the State of New York for individuals holding restricted clinical laboratory licenses. This amendment is significant as it allows for increased flexibility in the qualifications needed for laboratory work, particularly in specialized areas such as toxicology. The bill emphasizes that certified individuals can only perform toxicology testing in laboratories authorized by the state, ensuring compliance with stringent health standards and regulations.
Contention
Notable points of contention regarding A10564 may revolve around concerns over the adequacy of training for individuals obtaining restricted licenses with newly accepted certifications. Critics might argue that expanding certification requirements without proper oversight could lead to variations in competency among laboratory personnel, which could compromise the reliability of toxicology testing. Additionally, there is the potential for debate over what constitutes an appropriate certifying body and the definition of adequate training standards.
Overall_assessment
As A10564 progresses through the legislative process, it will be essential for stakeholders, including healthcare professionals and regulatory bodies, to evaluate the implications of these changes. Balancing the need for an appropriately trained workforce against the demand for flexible licensing requirements will be crucial as New York seeks to enhance its clinical laboratory services while ensuring public safety.
Same As
Expands the type of certifications that may be accepted by the state of New York for restricted licenses; requires individuals may only perform toxicology testing in a laboratory authorized by the state of New York.
Expands the type of certifications that may be accepted by the state of New York for restricted licenses; requires individuals may only perform toxicology testing in a laboratory authorized by the state of New York.
Relates to the definition of New York state labelled beer; provides that a licensed farm brewery shall manufacture or sell New York state labelled beer and may manufacture or sell beer other than New York state labelled beer that the licensee has manufactured provided that certain conditions are met.
Permits out-of-state clinical laboratories located within the United States to accept specimens from New York when there are no proper labs within the state recognized by the department of health.
Authorizes the issuance of a low potency cannabis beverage retail permit to licensed off-premises liquor and wine stores to allow the regulated sale of low potency cannabis single use beverages that contain no more than 5mg of THC manufactured by New York state adult-use licensees; provides for the allocation of low potency cannabis beverage tax revenue in the New York state cannabis revenue fund.
Authorizes the issuance of a low potency cannabis beverage retail permit to licensed off-premises liquor and wine stores to allow the regulated sale of low potency cannabis single use beverages that contain no more than 5mg of THC manufactured by New York state adult-use licensees; provides for the allocation of low potency cannabis beverage tax revenue in the New York state cannabis revenue fund.
Authorizes the issuance of a low potency cannabis beverage retail permit to licensed off-premises liquor and wine stores to allow the regulated sale of low potency cannabis single use beverages that contain no more than 5mg of THC manufactured by New York state adult-use licensees; provides for the allocation of low potency cannabis beverage tax revenue in the New York state cannabis revenue fund.